Neuberger Berman Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
13,382
-2,687
-17% -$46.9K ﹤0.01% 2180
2026
Q1
$308K Buy
16,069
+91
+0.6% +$1.98K ﹤0.01% 1825
2025
Q4
$351K Buy
15,978
+877
+6% +$15.8K ﹤0.01% 1744
2025
Q3
$183K Sell
15,101
-2,132
-12% -$28.9K ﹤0.01% 1921
2025
Q2
$321K Sell
17,233
-61
-0.4% -$1.21K ﹤0.01% 1711
2025
Q1
$331K Buy
17,294
+6,919
+67% +$202K ﹤0.01% 1668
2024
Q4
$374K Sell
10,375
-18
-0.2% -$609 ﹤0.01% 1612
2024
Q3
$441K Buy
10,393
+1,820
+21% +$77.2K ﹤0.01% 1558
2024
Q2
$345K Buy
8,573
+216
+3% +$9.01K ﹤0.01% 1607
2024
Q1
$296K Sell
8,357
-7,903
-49% -$212K ﹤0.01% 1648
2023
Q4
$481K Buy
+16,260
New +$337K ﹤0.01% 1713
2020
Q3
Sell
-15,096
Closed -$1.48M 1671
2020
Q2
$1.48M Sell
15,096
-7,904
-34% -$631K ﹤0.01% 1070
2020
Q1
$1.48M Sell
23,000
-501
-2% -$35.1K ﹤0.01% 1010
2019
Q4
$1.4M Buy
23,501
+1
+0% +$62 ﹤0.01% 1094
2019
Q3
$1.39M Buy
+23,500
New +$1.5M ﹤0.01% 1085

Other funds holding TNDM

Neuberger Berman Group's TNDM Position: Q2 2026 in Review

Neuberger Berman Group reduced its Tandem Diabetes Care (TNDM) stake by 17% in Q2 2026, selling an estimated $46.9K and leaving 13,382 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

Neuberger Berman Group first reported a position in TNDM in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.48M in Q2 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Neuberger Berman Group held 13,382 shares of Tandem Diabetes Care worth $202K as of Q2 2026.
  • Neuberger Berman Group sold 2,687 Tandem Diabetes Care shares in Q2 2026, an estimated $46.9K.
  • Tandem Diabetes Care made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2180 holding.
  • Neuberger Berman Group first reported a position in Tandem Diabetes Care in Q3 2019 and has held it in 15 quarters since.
  • Neuberger Berman Group's Tandem Diabetes Care position peaked at $1.48M in Q2 2020.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.